{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:30:40Z","timestamp":1792690240480,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Uniwersytet Medyczny w Lublinie","doi-asserted-by":"publisher","award":["DS 706"],"award-info":[{"award-number":["DS 706"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010621","name":"Uniwersytet Medyczny w Lublinie","doi-asserted-by":"publisher","award":["DS 37"],"award-info":[{"award-number":["DS 37"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Doxorubicin (DOX) is widely used in treatment; however, its efficacy is often compromised by multidrug resistance (MDR), limiting therapeutic outcomes. This study investigates the anticancer potential of diosmetin (DT), a metabolite of diosmin commonly used in chronic venous insufficiency, and its ability to enhance the efficacy of DOX in the treatment of breast cancer. Several breast cancer cell lines were used to assess the effects of DT and DOX on cell viability. The MCF-7 cell line, which showed the most significant effect, was selected for further investigation. The effects of DT on apoptosis, DNA damage, and P-glycoprotein expression and activity were analyzed. DT significantly enhanced DOX-induced apoptosis and DNA damage, while downregulating ABCB1 expression and activity, a key factor in MDR development. These findings highlight the potential of DT as a valuable adjuvant in breast cancer therapy by enhancing the efficacy of DOX. Its ability to overcome multidrug resistance mechanisms underlines its potential for future clinical trials aimed at developing effective treatments.<\/jats:p>","DOI":"10.1038\/s41598-025-16681-3","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T19:58:40Z","timestamp":1755806320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Enhancement of doxorubicin efficacy by diosmetin through DNA damage accumulation and P-glycoprotein inhibition in breast cancer cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Monika","family":"Michalczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Humeniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kubik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Adamczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariola","family":"Michalczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Madej-Czerwonka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Czerwonka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Korga-Plewko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"16681_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"16681_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold, M. et al. Current and Future Burden of Breast Cancer: Global Statistics for 2020 and 2040. Breast 66, 15\u201323. https:\/\/doi.org\/10.1016\/j.breast.2022.08.010 (2022).","journal-title":"Breast"},{"key":"16681_CR3","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.12659\/MSM.914058","volume":"25","author":"C Wang","year":"2019","unstructured":"Wang, C. et al. Anti-Proliferation and Pro-Apoptotic effects of Diosmetin via modulating cell cycle arrest and Mitochondria-Mediated intrinsic apoptotic pathway in MDA-MB-231 cells. Med. Sci. Monit. 25, 4639\u20134647. https:\/\/doi.org\/10.12659\/MSM.914058 (2019).","journal-title":"Med. Sci. Monit."},{"key":"16681_CR4","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.2147\/CMAR.S240064","volume":"12","author":"A Ma","year":"2020","unstructured":"Ma, A. & Zhang, R. Diosmetin inhibits cell proliferation, induces cell apoptosis and cell cycle arrest in liver cancer. Cancer Manag Res. 12, 3537\u20133546. https:\/\/doi.org\/10.2147\/CMAR.S240064 (2020).","journal-title":"Cancer Manag Res."},{"key":"16681_CR5","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.3390\/molecules24142522","volume":"24","author":"S Koosha","year":"2019","unstructured":"Koosha, S., Mohamed, Z., Sinniah, A. & Alshawsh, M. A. Evaluation of Anti-Tumorigenic effects of Diosmetin against human colon cancer xenografts in athymic nude mice. Molecules 24, 2522. https:\/\/doi.org\/10.3390\/molecules24142522 (2019).","journal-title":"Molecules"},{"key":"16681_CR6","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1021\/acs.molpharmaceut.7b01151","volume":"15","author":"A Roma","year":"2018","unstructured":"Roma, A., Rota, S. G. & Spagnuolo, P. A. Diosmetin induces apoptosis of acute myeloid leukemia cells. Mol. Pharm. 15, 1353\u20131360. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b01151 (2018).","journal-title":"Mol. Pharm."},{"key":"16681_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12032-021-01501-1","volume":"38","author":"F Zhao","year":"2021","unstructured":"Zhao, F. et al. Diosmetin induces apoptosis in ovarian cancer cells by activating reactive oxygen species and inhibiting the Nrf2 pathway. Med. Oncol. 38, 54. https:\/\/doi.org\/10.1007\/s12032-021-01501-1 (2021).","journal-title":"Med. Oncol."},{"key":"16681_CR8","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.3892\/mmr.2016.4872","volume":"13","author":"J Liu","year":"2016","unstructured":"Liu, J. et al. Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP\u20132 and MMP\u20139. Mol. Med. Rep. 13, 2401\u20132408. https:\/\/doi.org\/10.3892\/mmr.2016.4872 (2016).","journal-title":"Mol. Med. Rep."},{"key":"16681_CR9","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3892\/ijo.2018.4407","volume":"53","author":"C Oak","year":"2018","unstructured":"Oak, C. et al. Diosmetin suppresses human prostate cancer cell proliferation through the induction of apoptosis and cell cycle arrest. Int. J. Oncol. 53, 835\u2013843. https:\/\/doi.org\/10.3892\/ijo.2018.4407 (2018).","journal-title":"Int. J. Oncol."},{"key":"16681_CR10","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.3390\/molecules24183316","volume":"24","author":"M Feldo","year":"2019","unstructured":"Feldo, M. et al. Effect of diosmin administration in patients with chronic venous disorders on selected factors affecting angiogenesis. Molecules 24, 3316. https:\/\/doi.org\/10.3390\/molecules24183316 (2019).","journal-title":"Molecules"},{"key":"16681_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2298\/aci0804053m","volume":"55","author":"ZV Maksimovi\u0107","year":"2008","unstructured":"Maksimovi\u0107, Z. V., Maksimovi\u0107, M., Jadranin, D., Kuzmanovi\u0107, I. & Andonovi\u0107, O. Medicamentous treatment of chronic venous insufficiency using semisynthetic Diosmin\u2013a prospective study. Acta Chir. Iugosl. 55, 53\u201359. https:\/\/doi.org\/10.2298\/aci0804053m (2008).","journal-title":"Acta Chir. Iugosl."},{"key":"16681_CR12","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jpba.2009.09.012","volume":"51","author":"MA Campanero","year":"2010","unstructured":"Campanero, M. A. et al. Simultaneous determination of diosmin and Diosmetin in human plasma by ion trap liquid Chromatography\u2013Atmospheric pressure chemical ionization tandem mass spectrometry: application to a clinical Pharmacokinetic study. J. Pharm. Biomed. Anal. 51, 875\u2013881. https:\/\/doi.org\/10.1016\/j.jpba.2009.09.012 (2010).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"16681_CR13","first-page":"29","volume":"30","author":"D Cova","year":"1992","unstructured":"Cova, D., De Angelis, L., Giavarini, F., Palladini, G. & Perego, R. Pharmacokinetics and metabolism of oral diosmin in healthy volunteers. Int. J. Clin. Pharmacol. Ther. Toxicol. 30, 29\u201333 (1992).","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"16681_CR14","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.avsg.2012.10.020","volume":"27","author":"R Serra","year":"2013","unstructured":"Serra, R. et al. Breast cancer and venous disease: A retrospective cohort study. Ann. Vasc Surg. 27, 762\u2013766. https:\/\/doi.org\/10.1016\/j.avsg.2012.10.020 (2013).","journal-title":"Ann. Vasc Surg."},{"key":"16681_CR15","doi-asserted-by":"publisher","first-page":"R106","DOI":"10.1530\/VB-21-0013","volume":"3","author":"M Mclaughlin","year":"2021","unstructured":"Mclaughlin, M., Florida-James, G. & Ross, M. Breast cancer chemotherapy vascular toxicity: A review of mediating mechanisms and exercise as a potential therapeutic. Vasc Biol. 3, R106\u2013R120. https:\/\/doi.org\/10.1530\/VB-21-0013 (2021).","journal-title":"Vasc Biol."},{"key":"16681_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.26444\/aaem\/155382","volume":"30","author":"GM Adamczuk","year":"2023","unstructured":"Adamczuk, G. M., Humeniuk, E., Adamczuk, K., Madej-Czerwonka, B. & Dudka, J. Disruption of mitochondrial function augments the radiosensitivity of prostate cancer cell lines. Ann. Agric. Environ. Med. 30, 65\u201376. https:\/\/doi.org\/10.26444\/aaem\/155382 (2023).","journal-title":"Ann. Agric. Environ. Med."},{"key":"16681_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3390\/molecules28010420","volume":"28","author":"E Humeniuk","year":"2023","unstructured":"Humeniuk, E. et al. Cardioprotective effect of Centaurea castriferrei Borb\u00e1s & Waisb extract against Doxorubicin-Induced cardiotoxicity in H9c2 cells. Molecules 28, 420. https:\/\/doi.org\/10.3390\/molecules28010420 (2023).","journal-title":"Molecules"},{"key":"16681_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nprot.2006.5","volume":"1","author":"PL Olive","year":"2006","unstructured":"Olive, P. L. & Ban\u00e1th, J. P. The comet assay: A method to measure DNA damage in individual cells. Nat. Protoc. 1, 23\u201329. https:\/\/doi.org\/10.1038\/nprot.2006.5 (2006).","journal-title":"Nat. Protoc."},{"key":"16681_CR19","unstructured":"Rasband, W. & ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA.; (2011)."},{"key":"16681_CR20","first-page":"831","volume":"12","author":"SMD Rizvi","year":"2013","unstructured":"Rizvi, S. M. D., Shakil, S. & Haneef Mohd. A simple click by click protocol to perform docking: AutoDock 4.2 made easy for Non-Bioinformaticians. EXCLI J. 12, 831\u2013857 (2013).","journal-title":"EXCLI J."},{"key":"16681_CR21","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: automated Docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256 (2009).","journal-title":"J. Comput. Chem."},{"key":"16681_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/bip.21314","volume":"93","author":"O Deeb","year":"2010","unstructured":"Deeb, O., Rosales-Hern\u00e1ndez, M. C., G\u00f3mez-Castro, C., Gardu\u00f1o-Ju\u00e1rez, R. & Correa-Basurto, J. Exploration of human serum albumin binding sites by Docking and molecular dynamics flexible Ligand-Protein interactions. Biopolymers 93, 161\u2013170. https:\/\/doi.org\/10.1002\/bip.21314 (2010).","journal-title":"Biopolymers"},{"key":"16681_CR23","unstructured":"Syst\u00e8mes, D. & Free Download BIOVIA Discovery Studio Visualizer Available online: https:\/\/discover.3ds.com\/discovery-studio-visualizer-download (accessed on 28 March 2024)."},{"key":"16681_CR24","doi-asserted-by":"publisher","first-page":"7627","DOI":"10.1080\/07391102.2022.2123390","volume":"41","author":"A Kumar","year":"2023","unstructured":"Kumar, A., Kalra, S., Jangid, K. & Jaitak, V. Flavonoids as P-Glycoprotein inhibitors for multidrug resistance in cancer: an in-Silico approach. J. Biomol. Struct. Dynamics. 41, 7627\u20137639. https:\/\/doi.org\/10.1080\/07391102.2022.2123390 (2023).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"16681_CR25","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/bioinformatics\/btw230","volume":"32","author":"GY Di Veroli","year":"2016","unstructured":"Di Veroli, G. Y. et al. Combenefit: an interactive platform for the analysis and visualization of drug combinations. Bioinformatics 32, 2866\u20132868. https:\/\/doi.org\/10.1093\/bioinformatics\/btw230 (2016).","journal-title":"Bioinformatics"},{"key":"16681_CR26","doi-asserted-by":"publisher","first-page":"e4130","DOI":"10.21769\/BioProtoc.4130","volume":"11","author":"IM Roy","year":"2021","unstructured":"Roy, I. M., Nadar, P. S. & Khurana, S. Neutral comet assay to detect and quantitate DNA Double-Strand breaksin hematopoietic stem cells. Bio Protoc. 11, e4130. https:\/\/doi.org\/10.21769\/BioProtoc.4130 (2021).","journal-title":"Bio Protoc."},{"key":"16681_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S1734-1140(09)70018-0","volume":"61","author":"T \u0160im\u016fnek","year":"2009","unstructured":"\u0160im\u016fnek, T. et al. Anthracycline-Induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol. Rep. 61, 154\u2013171. https:\/\/doi.org\/10.1016\/S1734-1140(09)70018-0 (2009).","journal-title":"Pharmacol. Rep."},{"key":"16681_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.56.2.6","volume":"56","author":"G Minotti","year":"2004","unstructured":"Minotti, G. et al. Molecular advances and Pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 56, 185\u2013229. https:\/\/doi.org\/10.1124\/pr.56.2.6 (2004).","journal-title":"Pharmacol. Rev."},{"key":"16681_CR29","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1186\/s12885-018-4724-8","volume":"18","author":"B Denard","year":"2018","unstructured":"Denard, B., Jiang, S., Peng, Y. & Ye, J. CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to Doxorubicin-Based chemotherapy. BMC Cancer. 18, 813. https:\/\/doi.org\/10.1186\/s12885-018-4724-8 (2018).","journal-title":"BMC Cancer"},{"key":"16681_CR30","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1186\/s12885-019-5939-z","volume":"19","author":"C Christowitz","year":"2019","unstructured":"Christowitz, C. et al. Mechanisms of Doxorubicin-Induced drug resistance and drug resistant tumour growth in a murine breast tumour model. BMC Cancer. 19, 757. https:\/\/doi.org\/10.1186\/s12885-019-5939-z (2019).","journal-title":"BMC Cancer"},{"key":"16681_CR31","doi-asserted-by":"publisher","first-page":"30723","DOI":"10.18632\/oncotarget.15413","volume":"8","author":"Y Yang","year":"2017","unstructured":"Yang, Y. et al. Diosmetin exerts Anti-Oxidative, Anti-Inflammatory and Anti-Apoptotic effects to protect against Endotoxin-Induced acute hepatic failure in mice. Oncotarget 8, 30723\u201330733. https:\/\/doi.org\/10.18632\/oncotarget.15413 (2017).","journal-title":"Oncotarget"},{"key":"16681_CR32","doi-asserted-by":"publisher","first-page":"8232","DOI":"10.3390\/molecules27238232","volume":"27","author":"M W\u00f3jciak","year":"2022","unstructured":"W\u00f3jciak, M. et al. Antioxidant potential of diosmin and Diosmetin against oxidative stress in endothelial cells. Molecules 27, 8232. https:\/\/doi.org\/10.3390\/molecules27238232 (2022).","journal-title":"Molecules"},{"key":"16681_CR33","doi-asserted-by":"publisher","first-page":"107046","DOI":"10.1016\/j.intimp.2020.107046","volume":"89","author":"DH Lee","year":"2020","unstructured":"Lee, D. H., Park, J. K., Choi, J., Jang, H. & Seol, J. W. Anti-Inflammatory effects of natural flavonoid Diosmetin in IL-4 and LPS-Induced macrophage activation and atopic dermatitis model. Int. Immunopharmacol. 89, 107046. https:\/\/doi.org\/10.1016\/j.intimp.2020.107046 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"16681_CR34","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.3390\/molecules23092174","volume":"23","author":"R Russo","year":"2018","unstructured":"Russo, R., Chandradhara, D. & De Tommasi, N. Comparative bioavailability of two diosmin formulations after oral administration to healthy volunteers. Molecules 23, 2174. https:\/\/doi.org\/10.3390\/molecules23092174 (2018).","journal-title":"Molecules"},{"key":"16681_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13318-021-00731-y","volume":"47","author":"SH Gerges","year":"2022","unstructured":"Gerges, S. H., Wahdan, S. A., Elsherbiny, D. A. & El-Demerdash, E. Pharmacology of diosmin, a citrus flavone glycoside: an updated review. Eur. J. Drug Metab. Pharmacokinet. 47, 1\u201318. https:\/\/doi.org\/10.1007\/s13318-021-00731-y (2022).","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"16681_CR36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jchromb.2019.05.030","volume":"1124","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. Profiling and comparison of the metabolites of Diosmetin and diosmin in rat urine, plasma and feces using UHPLC-LTQ-Orbitrap MSn. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 1124, 58\u201371. https:\/\/doi.org\/10.1016\/j.jchromb.2019.05.030 (2019).","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"16681_CR37","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jconrel.2022.07.031","volume":"349","author":"PA Burnouf","year":"2022","unstructured":"Burnouf, P. A., Roffler, S. R., Wu, C. C., Su, Y. C. & Glucuronides From biological waste to Bio-Nanomedical applications. J. Control Release. 349, 765\u2013782. https:\/\/doi.org\/10.1016\/j.jconrel.2022.07.031 (2022).","journal-title":"J. Control Release"},{"key":"16681_CR38","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3892\/or_00000384","volume":"21","author":"VP Androutsopoulos","year":"2009","unstructured":"Androutsopoulos, V. P., Mahale, S., Arroo, R. R. J. & Potter, G. Anticancer effects of the flavonoid Diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation. Oncol. Rep. 21, 1525\u20131528. https:\/\/doi.org\/10.3892\/or_00000384 (2009).","journal-title":"Oncol. Rep."},{"key":"16681_CR39","doi-asserted-by":"publisher","first-page":"5148","DOI":"10.1038\/s41598-019-41685-1","volume":"9","author":"S Koosha","year":"2019","unstructured":"Koosha, S., Mohamed, Z., Sinniah, A. & Alshawsh, M. A. Investigation into the molecular mechanisms underlying the Anti-Proliferative and Anti-Tumorigenesis activities of Diosmetin against HCT-116 human colorectal cancer. Sci. Rep. 9, 5148. https:\/\/doi.org\/10.1038\/s41598-019-41685-1 (2019).","journal-title":"Sci. Rep."},{"key":"16681_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10030531","author":"S Kamran","year":"2022","unstructured":"Kamran, S., Sinniah, A., Chik, Z. & Alshawsh, M. A. Diosmetin exerts synergistic effects in combination with 5-fluorouracil in colorectal cancer cells. Biomedicines https:\/\/doi.org\/10.3390\/biomedicines10030531 (2022).","journal-title":"Biomedicines"},{"key":"16681_CR41","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1111\/bph.14652","volume":"176","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. Diosmetin induces apoptosis and enhances the chemotherapeutic efficacy of Paclitaxel in Non-Small cell lung cancer cells via Nrf2 Inhibition. Br. J. Pharmacol. 176, 2079\u20132094. https:\/\/doi.org\/10.1111\/bph.14652 (2019).","journal-title":"Br. J. Pharmacol."},{"key":"16681_CR42","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1080\/15384101.2020.1831257","volume":"19","author":"Z Hu","year":"2020","unstructured":"Hu, Z. et al. Diosmetin enhances the sensitivity of radiotherapy by suppressing homologous recombination in endometrial cancer. Cell Cycle 19, 3115\u20133126. https:\/\/doi.org\/10.1080\/15384101.2020.1831257 (2020).","journal-title":"Cell Cycle"},{"key":"16681_CR43","doi-asserted-by":"publisher","first-page":"e0175977","DOI":"10.1371\/journal.pone.0175977","volume":"12","author":"Z Xu","year":"2017","unstructured":"Xu, Z. et al. Radiosensitizing effect of Diosmetin on radioresistant lung cancer cells via Akt signaling pathway. PLOS ONE. 12, e0175977. https:\/\/doi.org\/10.1371\/journal.pone.0175977 (2017).","journal-title":"PLOS ONE"},{"key":"16681_CR44","first-page":"271","volume":"79","author":"X Yang","year":"1999","unstructured":"Yang, X. et al. MDR1 gene expression in primary and advanced breast cancer. Lab. Invest. 79, 271\u2013280 (1999).","journal-title":"Lab. Invest."},{"key":"16681_CR45","unstructured":"Zyad, A., B\u00e9nard, J., Tursz, T., Clarke, R. & Chouaib, S. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: Relationship to MDR1, MnSOD, and TNF gene expression. Cancer Res. (1994)."},{"key":"16681_CR46","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/0470846356.ch5","volume":"243","author":"A V\u00e1radi","year":"2002","unstructured":"V\u00e1radi, A., Szak\u00e1cs, G., Bakos, E. & Sarkadi, B. P. Glycoprotein and the mechanism of multidrug resistance. Novartis Found. Symp. 243, 54\u201365 (2002).","journal-title":"Novartis Found. Symp."},{"key":"16681_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2014.11.002","volume":"18","author":"RJ Kathawala","year":"2015","unstructured":"Kathawala, R. J., Gupta, P., Ashby, C. R. & Chen, Z. S. The modulation of ABC Transporter-Mediated multidrug resistance in cancer: A review of the past decade. Drug Resist. Updat. 18, 1\u201317. https:\/\/doi.org\/10.1016\/j.drup.2014.11.002 (2015).","journal-title":"Drug Resist. Updat"},{"key":"16681_CR48","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.drudis.2021.09.020","volume":"27","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei, S. et al. Advances in Understanding the role of P-Gp in doxorubicin resistance: molecular pathways, therapeutic strategies, and prospects. Drug Discovery Today. 27, 436\u2013455. https:\/\/doi.org\/10.1016\/j.drudis.2021.09.020 (2022).","journal-title":"Drug Discovery Today"},{"key":"16681_CR49","first-page":"2526","volume":"12","author":"M Pa\u0161kevi\u010di\u016bt\u0117","year":"2022","unstructured":"Pa\u0161kevi\u010di\u016bt\u0117, M. & Petrikait\u0117, V. Effect of natural flavonoids to reverse P-Glycoprotein-Related multidrug resistance in breast cancer cell cultures. Am. J. Cancer Res. 12, 2526\u20132538 (2022).","journal-title":"Am. J. Cancer Res."},{"key":"16681_CR50","doi-asserted-by":"publisher","first-page":"7620","DOI":"10.1021\/jf070893f","volume":"55","author":"HH Yoo","year":"2007","unstructured":"Yoo, H. H., Lee, M., Chung, H. J., Lee, S. K. & Kim, D. H. Effects of diosmin, a flavonoid glycoside in citrus fruits, on P-Glycoprotein-Mediated drug efflux in human intestinal Caco-2 cells. J. Agric. Food Chem. 55, 7620\u20137625. https:\/\/doi.org\/10.1021\/jf070893f (2007).","journal-title":"J. Agric. Food Chem."},{"key":"16681_CR51","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/cyto.990190207","volume":"19","author":"S Lahmy","year":"1995","unstructured":"Lahmy, S., Viallet, P. & Salmon, J. M. Is reduced accumulation of Hoechst 33342 in multidrug resistant cells related to P-Glycoprotein activity?? Cytometry 19, 126\u2013133. https:\/\/doi.org\/10.1002\/cyto.990190207 (1995).","journal-title":"Cytometry"},{"key":"16681_CR52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1432-1033.1997.00115.x","volume":"250","author":"AB Shapiro","year":"1997","unstructured":"Shapiro, A. B., Corder, A. B. & Ling, V. P. Hoechst 33342 transport out of the lipid bilayer. Eur. J. Biochem. 250, 115\u2013121. https:\/\/doi.org\/10.1111\/j.1432-1033.1997.00115.x (1997).","journal-title":"Eur. J. Biochem."},{"key":"16681_CR53","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/s0006-2952(96)00826-x","volume":"53","author":"AB Shapiro","year":"1997","unstructured":"Shapiro, A. B. & Ling, V. Effect of Quercetin on Hoechst 33342 transport by purified and reconstituted P-Glycoprotein. Biochem. Pharmacol. 53, 587\u2013596. https:\/\/doi.org\/10.1016\/s0006-2952(96)00826-x (1997).","journal-title":"Biochem. Pharmacol."},{"key":"16681_CR54","doi-asserted-by":"publisher","unstructured":"Quercetin and Doxorubicin Co-Delivery Using \u03b2-Cyclodextrin Nanocarrier Overcomes Multi-Drug Resistance in Cancer Cells via Targeting Akt\/NF-\u03baB\/ABCB1 Signaling Pathway | Request PDF. ResearchGate. (2025). https:\/\/doi.org\/10.1007\/s42247-024-00845-4","DOI":"10.1007\/s42247-024-00845-4"},{"key":"16681_CR55","doi-asserted-by":"publisher","first-page":"101004","DOI":"10.1016\/j.drup.2023.101004","volume":"71","author":"P Bharathiraja","year":"2023","unstructured":"Bharathiraja, P., Yadav, P., Sajid, A., Ambudkar, S. V. & Prasad, N. R. Natural medicinal compounds target signal transduction pathways to overcome ABC drug efflux Transporter-Mediated multidrug resistance in cancer. Drug Resist. Updat. 71, 101004. https:\/\/doi.org\/10.1016\/j.drup.2023.101004 (2023).","journal-title":"Drug Resist. Updat"},{"key":"16681_CR56","doi-asserted-by":"publisher","first-page":"12455","DOI":"10.3390\/ijms222212455","volume":"22","author":"TA Zughaibi","year":"2021","unstructured":"Zughaibi, T. A., Suhail, M., Tarique, M. & Tabrez, S. Targeting PI3K\/Akt\/mTOR pathway by different flavonoids: A cancer chemopreventive approach. Int. J. Mol. Sci. 22, 12455. https:\/\/doi.org\/10.3390\/ijms222212455 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"16681_CR57","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jnutbio.2018.09.022","volume":"63","author":"G Muthusamy","year":"2019","unstructured":"Muthusamy, G., Gunaseelan, S. & Prasad, N. R. Ferulic acid reverses P-Glycoprotein-Mediated multidrug resistance via Inhibition of PI3K\/Akt\/NF-\u03baB signaling pathway. J. Nutr. Biochem. 63, 62\u201371. https:\/\/doi.org\/10.1016\/j.jnutbio.2018.09.022 (2019).","journal-title":"J. Nutr. Biochem."},{"key":"16681_CR58","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.bcp.2012.01.002","volume":"83","author":"K Natarajan","year":"2012","unstructured":"Natarajan, K., Xie, Y., Baer, M. R. & Ross, D. D. Role of breast cancer resistance protein (BCRP\/ABCG2) in cancer drug resistance. Biochem. Pharmacol. 83, 1084\u20131103. https:\/\/doi.org\/10.1016\/j.bcp.2012.01.002 (2012).","journal-title":"Biochem. Pharmacol."},{"key":"16681_CR59","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/jps.21851","volume":"99","author":"AI Alvarez","year":"2010","unstructured":"Alvarez, A. I. et al. Modulation of the activity of ABC transporters (P-Glycoprotein, MRP2, BCRP) by flavonoids and drug response. J. Pharm. Sci. 99, 598\u2013617. https:\/\/doi.org\/10.1002\/jps.21851 (2010).","journal-title":"J. Pharm. Sci."},{"key":"16681_CR60","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2174\/1574892816666210218220943","volume":"16","author":"XY Chen","year":"2021","unstructured":"Chen, X. Y., Wang, J. Q., Yang, Y., Li, J. & Chen, Z. S. Natural product as substrates of ABC transporters: A review. Recent. Pat. Anticancer Drug Discov. 16, 222\u2013238. https:\/\/doi.org\/10.2174\/1574892816666210218220943 (2021).","journal-title":"Recent. Pat. Anticancer Drug Discov"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16681-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16681-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16681-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:57:24Z","timestamp":1757444244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16681-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16681"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16681-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30814"}}